The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Ji, Yuan
One or more keywords matched the following items that are connected to Ji, Yuan
Item TypeName
Concept Cell Division
Concept Clinical Trials, Phase I as Topic
Concept Clinical Trials, Phase II as Topic
Concept G2 Phase
Concept S Phase Cell Cycle Checkpoints
Academic Article Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios.
Academic Article Dose--schedule finding in phase I/II clinical trials using a Bayesian isotonic transformation.
Academic Article Dose-finding in phase I clinical trials based on toxicity probability intervals.
Academic Article Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
Academic Article Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trials.
Academic Article Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Academic Article An integrated dose-finding tool for phase I trials in oncology.
Academic Article A decision-theoretic phase I-II design for ordinal outcomes in two cycles.
Academic Article TEAMS: Toxicity- and Efficacy-based Dose Insertion Design with Adaptive Model Selection for Phase I/II Dose-Escalation Trials in Oncology.
Academic Article Toxicity and Efficacy Probability Interval Design for Phase I Adoptive Cell Therapy Dose-Finding Clinical Trials.
Academic Article A Bayesian hierarchical model for inference across related reverse phase protein arrays experiments.
Academic Article A Bayesian interval dose-finding design addressingOckham's razor: mTPI-2.
Academic Article R-TPI: rolling toxicity probability interval design to shorten the duration and maintain safety of phase I trials.
Academic Article The i3+3 design for phase I clinical trials.
Academic Article Bayesian continual reassessment method for dose-finding trials infusing T cells with limited sample size.
Academic Article Monitoring late-onset toxicities in phase I trials using predicted risks.
Academic Article Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma.
Academic Article Discussion of "A hybrid phase I-II/III clinical trial design allowing dose re-optimization in phase III" by Andrew G. Chapple and Peter F. Thall.
Academic Article [Studies of betuionic acid on cell cycle and related protein expressions on mice of bearing H22 tumor cells].
Academic Article Downregulation of Cdk1 and cyclinB1 expression contributes to oridonin-induced cell cycle arrest at G2/M phase and growth inhibition in SGC-7901 gastric cancer cells.
Academic Article Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease.
Academic Article A Multi-Arm Two-Stage (MATS) design for proof-of-concept and dose optimization in early-phase oncology trials.
Search Criteria
  • Cell Division